A Randomized, Multiple-Dose, Crossover Study Characterizing the Pharmacodynamic Profiles of Formoterol Fumarate Inhalation Solution and Formoterol Dry Powder Inhaler in Subjects With Stable Chronic Obstructive Pulmonary Disease.
Phase of Trial: Phase II
Latest Information Update: 24 May 2013
At a glance
- Drugs Formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Mylan Specialty
- 03 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Aug 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 14 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.